Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2018-02-23, Stock:JNJ, The news for the past five days is as follows:
2018-02-15: NEWS1: Glancy Prongay & Murray LLP Continues Investigation on Behalf of Johnson & Johnson Investors (JNJ).NEWS2: 6 Healthcare Stocks We Think Deserve Gold Medals (Hint: One's a Marijuana Stock).NEWS3: 6 Healthcare Stocks We Think Deserve Gold Medals (Hint: One's a Marijuana Stock).NEWS4: A Snapshot Of Abbott Labs' Business.NEWS5: A Snapshot Of Abbott Labs' Business.NEWS6: The Klein Law Firm Notifies Investors of an Investigation Concerning Possible Violations of Federal Securities Laws by Johnson & Johnson.NEWS7: 6 Healthcare Stocks We Think Deserve Gold Medals (Hint: One&apos;s a Marijuana Stock).NEWS8: J&J (JNJ) Gets FDA Nod for New Prostrate Cancer Treatment.NEWS9: J&J (JNJ) Gets FDA Nod for New Prostrate Cancer Treatment.NEWS10: J&J (JNJ) Gets FDA Nod for New Prostrate Cancer Treatment.NEWS11: How Pfizer’s Peri-LOE Products Performed in 2017.NEWS12: Today’s Research Reports on Trending Tickers: Johnson & Johnson and Merck & Company.NEWS13: See what the IHS Markit Score report has to say about Johnson & Johnson..NEWS14: Where Pfizer’s Xeljanz Is Positioned for 2018.NEWS15: How Analysts View Bristol-Myers Squibb after Its 4Q17 Earnings.NEWS16: Why Defensive ETFs Fail in the Market Downturn?.NEWS17: Why Defensive ETFs Fail in the Market Downturn?.
2018-02-16: NEWS1: Stocks stretch winning streak to 6 days despite turbulence.NEWS2: Stocks stretch winning streak to 6 days despite turbulence.NEWS3: How Much Is Roche's Phase 3 Drug Pipeline Worth?.NEWS4: How Much Is Roche's Phase 3 Drug Pipeline Worth?.NEWS5: How Cosentyx Resolves Enthesitis in Psoriatic Arthritis Patients.NEWS6: Novartis’s Cosentyx May Emerge as a Leading Psoriasis Drug.NEWS7: This Biotech Stock May Need Anesthesia After Collapsing Nearly 20%.NEWS8: This Biotech Stock May Need Anesthesia After Collapsing Nearly 20%.NEWS9: The Klein Law Firm Reminds Investors of an Investigation Concerning Possible Violations of Federal Securities Laws by Johnson & Johnson.NEWS10: Aimovig as Prophylaxis Therapy in Chronic and Episodic Migraine.NEWS11: Coca-Cola earnings show the beverage business—not bottling—is booming.NEWS12: Pfizer on the Street: Analyst Recommendations in February 2018.NEWS13: Johnson & Johnson Consumer Presents New Scientific Research At 2018 American Academy of Dermatology Annual Meeting.NEWS14: Why Teva Pharmaceutical Stock Soared More than 10% on Thursday.NEWS15: AbbVie Hikes Dividend by 35%, Launches $10B Buyback Plan.NEWS16: AbbVie Hikes Dividend by 35%, Launches $10B Buyback Plan.NEWS17: Dow 30 Stock Roundup: Cisco Beats, Caterpillar January Sales up 34%.NEWS18: Dow 30 Stock Roundup: Cisco Beats, Caterpillar January Sales up 34%.NEWS19: Merck’s Immunology and Cardiovascular Products in 4Q17.NEWS20: Dow 30 Stock Roundup: Cisco Beats, Caterpillar January Sales up 34%.NEWS21: Parsing Alphabet’s Other Bets Business.NEWS22: J&J (JNJ) Gets FDA Nod for New Prostate Cancer Treatment (Revised).NEWS23: J&J (JNJ) Gets FDA Nod for New Prostate Cancer Treatment (Revised).NEWS24: J&J (JNJ) Gets FDA Nod for New Prostate Cancer Treatment (Revised).NEWS25: 4 Dow Jones Heavyweights That Are Still on the Ropes.NEWS26: 4 Dow Jones Heavyweights That Are Still on the Ropes.
2018-02-20: NEWS1: Johnson & Johnson to Participate in Cowen 38th Annual Healthcare Conference.NEWS2: JNJ INVESTOR ALERT: Law Offices of Howard G. Smith Continues Investigation on Behalf of Johnson & Johnson Investors.NEWS3: How Are Roche's Revenues And Earnings Likely To Change Over The Next Five Years?.NEWS4: How Are Roche's Revenues And Earnings Likely To Change Over The Next Five Years?.NEWS5: SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Johnson & Johnson of a Class Action Lawsuit and a Lead Plaintiff Deadline of April 9, 2018 – JNJ.NEWS6: ITOT, JPM, JNJ, XOM: Large Inflows Detected at ETF.NEWS7: ITOT, JPM, JNJ, XOM: Large Inflows Detected at ETF.NEWS8: How Did JNJ’s Surgical Devices Segment Perform in 4Q17 and 2017?.NEWS9: What's in the Cards for Geron (GERN) This Earnings Season?.NEWS10: What's in the Cards for Geron (GERN) This Earnings Season?.NEWS11: How JNJ’s Orthopedic Medical Devices Performed in 4Q17 and 2017.NEWS12: SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against Johnson & Johnson (JNJ) & Lead Plaintiff Deadline - April 9, 2018.NEWS13: US Tax Reform Impacted Boston Scientific’s Profits in 4Q17.NEWS14: A Look at Johnson & Johnson’s Medical Devices Business in 2017.NEWS15: What&apos;s in the Cards for Geron (GERN) This Earnings Season?.NEWS16: See what the IHS Markit Score report has to say about Johnson & Johnson..NEWS17: [$$] US companies might be liquidating their offshore bond hoards.
2018-02-21: NEWS1: There Are Better Options Than Medtronic PLC Stock.NEWS2: There Are Better Options Than Medtronic PLC Stock.NEWS3: Why TG Therapeutics Stock Jumped 10% Today.NEWS4: Johnson & Johnson to start vertical construction on $18M Lake Nona facility.NEWS5: INVESTOR ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Johnson & Johnson of Commencement of a Class Action Lawsuit and a Lead Plaintiff Deadline of April 9, 2018.NEWS6: Can Johnson & Johnson Replace Remicade for $100 Million Upfront?.NEWS7: Can Johnson & Johnson Replace Remicade for $100 Million Upfront?.NEWS8: Can Johnson & Johnson Replace Remicade for $100 Million Upfront?.NEWS9: How Did JNJ’s Vision Care Segment Perform in 4Q17 and 2017?.NEWS10: Novartis Expects FDA and EMA Approvals for Aimovig in 2018.
2018-02-22: NEWS1: Dow Adds 165 Points; Nasdaq Suffers 4th Straight Loss.NEWS2: Dow Adds 165 Points; Nasdaq Suffers 4th Straight Loss.NEWS3: JNJ’s Consumer Products: OTC, Women’s Health, and Wound Care.NEWS4: JNJ SHAREHOLDER ALERT: The Law Offices of Vincent Wong Notifies Investors of Commencement of a Class Action Involving Johnson & Johnson and a Lead Plaintiff Deadline of April 9, 2018.NEWS5: How Much Has Roche Paid In Dividends Over The Last Five Years?.NEWS6: How Much Has Roche Paid In Dividends Over The Last Five Years?.NEWS7: INVESTOR ALERT: Brower Piven Encourages Shareholders Who Have Losses In Excess Of $100,000 From Investment In Johnson & Johnson To Contact Brower Piven Before The Lead Plaintiff Deadline In Class Action Lawsuit.NEWS8: Update on JNJ’s Consumer Products: Baby Care, Beauty, and Oral Care.NEWS9: Abbott Laboratories’ 377th Consecutive Quarterly Dividend.NEWS10: Why Is Johnson & Johnson (JNJ) Down 8.5% Since its Last Earnings Report?.NEWS11: Why Is Johnson & Johnson (JNJ) Down 8.5% Since its Last Earnings Report?.NEWS12: A Look at Eli Lilly’s 4Q17 Revenue.NEWS13: How Johnson & Johnson Performed in 4Q17 and Fiscal 2017.NEWS14: Why Is Johnson & Johnson (JNJ) Down 8.5% Since its Last Earnings Report?.NEWS15: Ex-Dividend Reminder: Johnson & Johnson, BGC Partners and KeyCorp.NEWS16: Ex-Dividend Reminder: Johnson & Johnson, BGC Partners and KeyCorp.NEWS17: February Pharma And Biotech Dividend Stocks To Look Out For.NEWS18: Why TG Therapeutics Stock Jumped 10% Today.NEWS19: Why TG Therapeutics Stock Jumped 10% Today.

Answer: Rise